Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients
While new cardiac research is published every day, some clinical trials make a more significant impact than others. The SMART (SMall Annuli Randomized To EvolutTM or SAPIENTM*) trial¹, for example, explored differences between patients with a small aortic annulus who were treated with supra-annular, self-expanding EvolutTM valves from Medtronic and those treated with intra-annular, balloon-expandable SAPIEN 3TM valves from Edwards Lifesciences.
